Investigation of three common centrifugation protocols for platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam: a prospective trial.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 16 03 2023
accepted: 14 08 2023
medline: 9 10 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: ppublish

Résumé

Different platelet-rich fibrin (PRF) protocols exist and are known to differ in resulting mechanical and bioactive properties. Centrifugation parameters may also influence drug release, in particular antibiotics, when using PRF as a bio-carrier. We thus evaluated three common protocols regarding effects on the bio-carrier properties. In a prospective trial comprising 33 patients, we compared different protocols for PRF as a bio-carrier for ampicillin/sulbactam (SAM). Blood samples were taken shortly after a single dose of ampicillin/sulbactam (2 g/1 g) was administered to patients intravenously. PRF was obtained by centrifugation and three protocols were used: protocol A (1300 rpm, 8 min, RCF-max = 208 g), B (2300 rpm, 12 min, RCF-max = 652 g), and C (1500 rpm, 14 min, RCF-max = 276 g). The antibacterial activity of PRF was investigated against five oral species in vitro, based on agar diffusion methodology. The study demonstrates that a single dose of SAM is sufficient to reach high concentrations in PRF in all protocols (150 µg/ml), which is comparable to the plasma SAM concentration. Antibacterial activity was inferred from the diameter of inhibition zones seen in agar diffusion tests using PRF discs. Protocol B resulted in the largest inhibition zones. One-way ANOVA revealed statistically improved results for protocol B for some bacteria. The study provides valuable data on PRF antibiotic enrichment, notably SAM. A single dose of SAM is sufficient to reach clinically relevant concentrations in PRF. These findings potentially extend the application of PRF, for example in patients with osteonecrosis of the jaw or in oral surgery (e.g., stick bone).

Identifiants

pubmed: 37603167
doi: 10.1007/s00784-023-05212-x
pii: 10.1007/s00784-023-05212-x
pmc: PMC10560174
doi:

Substances chimiques

sultamicillin 65DT0ML581
Sulbactam S4TF6I2330
Agar 9002-18-0
Intercellular Signaling Peptides and Proteins 0
Anti-Bacterial Agents 0
Ampicillin 7C782967RD

Types de publication

Journal Article

Langues

eng

Pagination

5991-5998

Informations de copyright

© 2023. The Author(s).

Références

J Oral Implantol. 2014 Dec;40(6):679-89
pubmed: 24945603
BMC Oral Health. 2021 Mar 19;21(1):135
pubmed: 33740959
Materials (Basel). 2022 Feb 16;15(4):
pubmed: 35208017
Int J Clin Pharmacol Ther. 1998 May;36(5):253-7
pubmed: 9629988
Clin Oral Investig. 2017 Jul;21(6):1913-1927
pubmed: 28551729
J Dent Sci. 2020 Jun;15(2):141-146
pubmed: 32595893
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Sep;110(3):275-8; author reply 278-80
pubmed: 20727495
Clin Microbiol Infect. 2014 Apr;20(4):O255-66
pubmed: 24131428
Infection. 1994 Mar-Apr;22(2):149-51
pubmed: 8070929
Polymers (Basel). 2022 Mar 29;14(7):
pubmed: 35406263
Clin Oral Investig. 2017 Nov;21(8):2619-2627
pubmed: 28154995
J Clin Med. 2022 Jun 17;11(12):
pubmed: 35743574
Acta Biomater. 2018 Jul 15;75:35-51
pubmed: 29772345
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S503-11
pubmed: 3025997
Antimicrob Agents Chemother. 1991 Sep;35(9):1772-6
pubmed: 1952846
J Clin Periodontol. 2019 Feb;46(2):241-247
pubmed: 30629300
Eur J Trauma Emerg Surg. 2018 Feb;44(1):87-95
pubmed: 28283682
J Pharm Biomed Anal. 2021 Mar 20;196:113899
pubmed: 33508765
Int J Oral Sci. 2020 Nov 26;12(1):32
pubmed: 33243983
Platelets. 2016 Jun;27(4):276-85
pubmed: 26763769
Platelets. 2021 Apr 3;32(3):413-419
pubmed: 32306811
Clin Oral Investig. 2021 May;25(5):2801-2809
pubmed: 33006027
Infection. 1997 Jul-Aug;25(4):258-62
pubmed: 9266270
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e37-44
pubmed: 16504849
Eur J Trauma Emerg Surg. 2019 Jun;45(3):467-479
pubmed: 28324162
Adv Exp Med Biol. 2022;1369:33-51
pubmed: 33963526
Sci Rep. 2021 Mar 16;11(1):6038
pubmed: 33727689
Int J Environ Res Public Health. 2022 Nov 13;19(22):
pubmed: 36429636
Molecules. 2022 Mar 22;27(7):
pubmed: 35408442
J Periodontol. 2017 Jan;88(1):112-121
pubmed: 27587367
Clin Oral Investig. 2022 Dec;26(12):7033-7044
pubmed: 35941396
Indian J Dent Res. 2016 May-Jun;27(3):300-4
pubmed: 27411660
J Clin Periodontol. 2023 Mar;50(3):358-367
pubmed: 36330669
J Mater Sci Mater Med. 2017 Oct 25;28(12):188
pubmed: 29071440
J Periodontol. 2019 Aug;90(8):817-820
pubmed: 30730050
Mund Kiefer Gesichtschir. 2005 Jul;9(4):214-9
pubmed: 15926086
Dent Clin North Am. 2020 Apr;64(2):291-303
pubmed: 32111269

Auteurs

Anton Straub (A)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany. Straub_A@ukw.de.

Chiara Utz (C)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Maximilian Stapf (M)

Institute for Pharmacy and Food Chemistry of the University of Würzburg, Am Hubland, 97074, Würzburg, Germany.

Andreas Vollmer (A)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Sylvia Kasper (S)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Alexander C Kübler (AC)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Roman C Brands (RC)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Stefan Hartmann (S)

Department of Oral and Maxillofacial Plastic Surgery of the University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Thiên-Trí Lâm (TT)

Institute for Hygiene and Microbiology of the University of Würzburg, Josef-Schneider-Street 2/E1, 97080, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH